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Abstract
Modern cancer treatments have substantially improved cure rates and have
generated a great interest in and need for proper statistical tools to analyze
survival data with non-negligible cure fractions. Data with cure fractions are
often complicated by dependent censoring, and the analysis of this type of
data typically involves untestable parametric assumptions on the dependence
of the censoring mechanism and the true survival times. Motivated by the
analysis of prostate cancer survival trends, we propose a class of semiparametric
transformation cure models that allows for dependent censoring without making
parametric assumptions on the dependence relationship. The proposed class
of models encompasses a number of common models for the latency survival
function, including the proportional hazards model and the proportional odds
model, and also allows for time-dependent covariates. An inverse censoring
probability reweighting scheme is used to derive unbiased estimating equations.
We validate small sample properties with simulations and demonstrate the
method with a data application.

Keywords: Estimating equation, proportional hazards model, proportional odds
model, right censoring, transformation model.

1.

Introduction

Survival models incorporating a cure fraction are an important statistical tool for
analyzing cancer survival data. Research for many cancer types, including prostate
and breast cancer, non-Hodgkin’s lymphoma, leukemia, melanoma, and head and
neck cancer, has shown that a significant proportion of patients with these cancers
are cured after therapy; that is, an individual will have little or no risk of experiencing
the event of interest, e.g. breast cancer, after treatment. Cure survival models are
1
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often developed assuming the study population is a mixture of cured and not cured
subjects (Berkson and Gage 1952; Farewell 1982; Kuk and Chen 1992; Peng and
Dear 2000; Sy and Taylor 2000). Recently, Lu and Ying (2004) used the mixture
formulation to extend a class of semiparametric transformation models proposed by
Cheng, Wie, and Ying (1995) to incorporate cure fractions. An alternative to the
mixture cure formulation is the promotion cure model, which is popular for Bayesian
cure survival analysis and has an attractive biological interpretation (Chen, Ibrahim,
and Sinha 1999; Tsodikov, Ibrahim, and Yakovlev 2003). The promotion cure model
has one covariate function that describes both the survival and cure components.
In contrast, the two components of the mixture cure model can depend on different
parameters, allowing for separate covariate interpretations for the cure function and
for the survival function for those who are not cured.
A key assumption made in the literature is independence between the survival
time and the censoring time, but such an assumption is often violated in observational studies. For example, in our motivating study a non-negligible number of
patients diagnosed with prostate cancer were found to have died from cardiovascular
disease. Research has shown that prostate cancer and heart disease share high fat diet
as a common risk factor (Wilson et al. 1998; Strom et al. 2008). Therefore, assuming
independence between the main end point (death from prostate cancer) and censoring causes (e.g. death from heart disease) is problematic. Dependent censoring will
often hamper statistical analysis since classical models will not be valid, and ignoring
dependent censoring will typically introduce bias (Li, Tiwari, and Guha 2007). To
account for this, Li et al. (2007) developed a cure model in the presence of dependent
censoring, but their model requires a priori assumptions on the dependence structure
and does not allow for covariates.
In this project, we propose a semiparametric transformation model which allows
2
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for covariates as well as dependent censoring. The key idea is to use an inverse
censoring probability reweighting scheme to derive unbiased estimating equations
that account for dependent censoring. In this manner, we are able to avoid making
parametric assumptions about the dependence structure between the survival time
and the censoring time. It is also worth noting that our proposed model, which
accommodates time-dependent covariates, is more general than that proposed by Lu
and Ying (2004), which only allows for time-independent covariates.
Broadly speaking, this project advances the field in three distinct ways. First, the
proposed methods can be used to investigate trends in Surveillance Epidemiology and
End Results (SEER) cancer survival data (www.seer.cancer.gov); a number of cancer
sites in the SEER database may indicate cure patterns, including prostate, colon, and
ovarian cancer (Tai et al. 2005). Second, survival studies with cure fractions are subject to heavy censoring that is likely to violate the traditional independent censoring
assumption. This project addresses the problem by developing methods that can accommodate dependent censoring, and by providing procedures for model diagnostics
and techniques for statistical inference. The proposed estimation procedure successfully avoids parametric assumptions on the joint distribution of the censoring and
true failure times, which have caused difficulties in the study of dependent censoring
in the existing literature. Finally, the theoretical proofs developed in this project
provide an original application of empirical process theory and functional analysis
techniques, which will be valuable for semiparametric estimation.
The rest of the paper is stuctured as follows: in Section 2 we define notation and
set up the survival model. In Section 3 we define the weight function. Section 4 uses
the results of Sections 2 and 3 to define estimating equations and provides theoretical
results. Section 5 summarizes a computational algorithm and a weighted bootstrap
method for inference procedures on the estimating equations. Section 6 provides
3
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a model checking procedure. In Section 7 we present simulation results and data
analysis findings. Section 8 contains a short discussion. Sketches of proofs of theorems
are contained in the Appendix.

2.

A Class of Semiparametric Models

Denote the failure time for a patient by T , which is assumed to have the decomposition
T = ηT ∗ + (1 − η)∞, where η ∈ {0, 1} indicates whether the sampled subject is cured
(η = 0) or not (η = 1), and T ∗ , with support on [0, ∞), denotes the failure time if
the patient is not cured. Let C denote the censoring time, X a κ length vector of
covariates related to the cure indicator η, which includes 1, and Z(·) a ξ length vector
of external time-dependent covariates related to T ∗ that may share time-independent
components with X. Define T̃ = min(T, C), ∆ = I(T ≤ C), a counting process
related to the survival progress N(t) = I(T̃ ≤ t, ∆ = 1), and the at-risk process
Y (t) = I(T̃ ≥ t). In practice, we observe (T̃i , ∆i , Zi (·), Xi), for i = 1, . . . , n, which
are independent and identically distributed copies of (T̃ , ∆, Z(·), X). To ensure that
we have unbiased estimates for our parameters we assume that the support of the
censoring time is not shorter than the support of the failure time (Fine, Ying, and
Wei 1998; Fine 1999).
Using the above notation, we can define a model for T . Following Farewell (1982),
we use a logistic model for the cure indicator η:
P (η = 1|X, Z) = G(γ ′ X),

(1)

where G(x) = exp(x)/(1 + exp(x)). Among patients who are not cured, we assume
that given the covariate path Z̄(t) = {Z(u), u ≤ t}, T ∗ possesses the following survival

4
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function:
Sg (t; Z̄(t)) = g

nZ

0

t

o
exp(β Z(u)) dH(u) ,
′

(2)

where H is a fixed but unspecified nondecreasing function with H(0) = 0, and
g is a known continuous and strictly decreasing function such that g(0) = 1 and
limt→∞ g(t) = 0. This model has been considered in Kosorok and Song (2007) and
Zeng and Lin (2007). Zeng and Lin (2007) suggested extending their model to cure
applications in future research; in contrast to our proposal, their work assumed conditional independence between T and C. The survival function for the noncured
subjects, Sg (·), is commonly referred to as the latency survival function. The formulation of (2) is comprehensive: when g(x) = 1/(1 + x) the resulting model is
a time-dependent construction of the proportional odds model (Bennett 1983), and
when g(x) = exp(−x) the model reduces to the time-dependent proportional hazards
model (Cox 1972).
Combining (1) and (2), we can describe the survival function for T as

P (T ≥ t|Z̄(t), X) = g

nZ

0

t

o
exp(β ′ Z(u)) dH(u) G(γ ′ X) + Ḡ(γ ′ X),

(3)

where Ḡ(x) = 1 − G(x). Let W(·) denote the external time-dependent covariate
process associated with censoring and let W̄(t) = {W(u), u ≤ t} denote the covariate path associated with W(·). We assume that P (T ≥ t|Z̄(t), X) = P (T ≥
t|Z̄(t), X, W̄(t)), i.e. that W̄(t) does not contain any extra information for T beyond
what is already in Z̄(t) and X.

3.

A Reweighting Scheme for Dependent Censoring

We wish to make minimal assumptions on the dependence between T and C, and so
it will not be feasible to construct likelihood-based inference procedures. Instead, we
5
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will derive unbiased estimating equations for β, the parameter associated with the
latency survival function, and γ, the parameter associated with the cure function. To
this end, we first define some notation related to the censoring process. Define the
crude hazard for censoring as
λc (t|W̄(t)) = lim (dt)−1 P (C ∈ (t, t + dt), ∆ = 0|T̃ ≥ t, W̄(t))
dt→0

(4)

which can also be regarded as a cause specific hazard. Conveniently, (4) can be estimated with observed data even when T and C are dependent (Fleming and Harrington
1991, Theorem 1.3.1).
We make the following assumption on the crude hazard for censoring:

λc (t|W̄(t), T, T > t) = λc (t|W̄(t), T > t).

This assumption implies that, conditional on the covariate process W̄(t), the crude
hazard for censoring at time t does not further depend on the possibly unobserved
failure time. This assumption has been described as “no unmeasured confounders
for censoring” and the assumption would fail if a covariate related to both T and C
were not included in W̄(t) (Robins and Finkelstein 2000). This assumption has been
well discussed for semiparametric survival problems in the literature with examples
and information on how to select covariates for W̄(t) (Robins 1992; Robins and
Rotnitzky 1992; Robins 1993; Rotnitzky and Robins 1995; Robins and Finkelstein
2000; Rotnitzky and Robins 2003; Miloslavsky, Keles, Laan, and Butler 2004).
Flexible models on λc (t|W̄(t)) can be considered. For example, if αE is the

6
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parameter vector associated with W(·), we could write the crude hazard function as
λc (t|W̄(t)) = λ0 (t) exp(α′E W(t)),

(5)

where λ0 (t) is left unspecified.
Rt
Q
Let Λc (t|W̄(t)) = 0 λc (u|W̄(u)) du and K(t|W̄(t)) = u≤t (1 − dΛc (u|W̄(u))).

Throughout we will write K(t|W̄(t)) = K(t). Note that if all the components of

W(·) are time-independent and T and C are independent, then K(t) = P (C > t|W)
and K(t) can be interpreted as the probability that a person with covariate W is
not censored up to time t. This interpretation does not hold in general as the crude
hazard λc (t) is not equal to the net hazard of censoring when T and C are dependent.
Similar arguments as in Robins (1993) lead to

E[I(T̃ ∈ (t, t + dt), ∆ = 1)/K(T̃ −)] = P (T ∈ (t, t + dt))
and

E[I(T̃ ≥ t)/K(t−)] = P (T ≥ t).

(6)
(7)

These equations imply that the reweighted sample of patients observed to fail at time
t is representative of all patients who fail at time t and that the reweighted sample
of patients who have not failed by time t is representative of the general survival
probability of all patients at time t.

4.

Estimating Equations and Theoretical Results

Equations (6) and (7) are important as they hold even when T and C are dependent,
and we can use them to derive estimating equations for the unknown regression parameters β and γ, and the function H. Specifically, (6) implies that E[dN(t)/K(t−)+
dP (T ≥ t|Z̄(t), X)] = 0, or, equivalently, EW [E[dN(t)+K(t−) dP (T ≥ t|Z̄(t), X)|W]] =

7
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0; while (7) implies that EW [E[Y (t) − K(t−)P (T ≥ t|Z̄(t), X)|W]] = 0. Together
these constitute a basis for estimation. Here, P (T ≥ t|Z̄(t), X) is specified in Equation (3) and dP (·) is the derivative of Equation (3) with respect to t.
Let α denote the parameters associated with K(·); define θ = (α, β, γ, H) and
write the true value of θ as θ 0 = (α0 , β 0 , γ 0 , H0 ). Denote the estimating equations
associated with α as Unα (α). In the following, the subscript i marks individuals.
Define

µβ ,i(θ) =
µγ ,i(θ) =
µH,i(θ)(t) =

ν

Z

Zi (u)[dNi (u) + Ki (u−)G(γ ′ Xi ) dSg (u; Z̄i (u))]

Z0 ν
Z0 t

Xi [Yi(u) − Ki (u−)[G(γ ′ Xi )Sg (u; Z̄i (u)) + Ḡ(γ ′ Xi)]] du
dNi (u) + Ki (u−)G(γ ′ Xi ) dSg (u; Z̄i (u)).

0

A natural set of estimating equations for β, γ and H using (3) and our results from
(6), and (7) is:

Unβ (θ)

def

=

n
X

µβ ,i (θ)

(8)

n
X

µγ ,i (θ)

(9)

i=1

Unγ (θ)
UnH (θ)(t)

def

=

def

=

i=1
n
X
i=1

µH,i (θ)(t), ∀ t ∈ [0, ν].

(10)

In the above, choose ν to be a constant such that P (T̃ > ν) > č > 0 for some
fixed č. The constraint on ν is imposed to avoid tail instability associated with large
values of t. In practice the weight function K(·) is unknown and can be replaced
with an empirical estimator. This is easily done by replacing Λc (u|W̄(u)) in the
definition of K(t) with a consistent estimate Λ̂c (u|W̄(u)). Since the left term of UnH

8
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only jumps at observed failure times, the estimate for H will be a step-function that
jumps at the observed failure times. Let Un (θ) = (Unα , Unβ , Unγ , UnH )(θ) and
define U(θ) = EUn (θ).
To make the definition of Unα more concrete, we provide an example where
the crude hazard for censoring (Equation (4)), follows a proportional hazards model
(Equation (5)). In this case we can decompose α into two parts (αE , αΛ ) where
αE represents the Euclidean parameter of the model and αΛ denotes the baseline
cumulative hazard function for the model. The estimating equations associated with
(αE , αΛ ) are the usual partial likelihood score equations and the Breslow formula for
the cumulative hazard:

UnαE (α) =
UnαΛ (α)(t) =

n Z
X

ν

i=1 0
n Z t
X
i=1

0

Wi (u)(dNci(u) − Yi (u) exp(α′E Wi (u)) dΛ0(u))
dNci(u) − Yi (u) exp(α′E Wi (u)) dΛ0(u),

∀ t ∈ [0, ν]

where Nci (t) = I(T̃i ≤ t, ∆i = 0) for i = 1, . . . , n, and Λ0 (·) is the baseline cumulative hazard function. For this proportional hazards case we would write Unα =
(UnαE , UnαΛ )′ .
Define θ̂ = (α̂, β̂, γ̂, Ĥ) as zeroes of Un (θ) = (Unα , Unβ , Unγ , UnH )(θ). In
general one is interested in the zeroes of (8) and (9), which we denote φ̂ = (β̂, γ̂).
We note that the asymptotic variance formula for n1/2 (φ̂ − φ) is analytically so
complicated that it will be of limited computational utility. Instead, we propose an
application of a weighted bootstrap, which is introduced in Section 5 and is shown
to yield a consistent estimate for the variance. We will write the weighted bootstrap
version of Un (θ) by Un (θ)∗ and denote the weighted bootstrap estimate of θ from
∗

Un (θ)∗ as θ̂ .

9
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Conditions for and sketches of proofs for the following asymptotic results are
contained in the Appendix.
Theorem 1. Under regularity conditions (c.1)–(c.4), the survival model in Equation
(3) is identifiable.
This result is more general than that for cure survival models provided by Li,
Taylor, and Sy (2001) since time-dependent cure proportional odds and proportional
hazards models are included in our result as special cases. Further, in contrast to Li
et al. (2001), we do not require the value zero to be in the support of the covariates,
which may not be a realistic assumption in many situations. As pointed out by a
reviewer, a key component of the identifiability result is the presence of covariates
in both components of the mixture model. In fact, Li et al. (2001) show that if the
latency survival function is nonparameteric and independent of covariates and if the
cure fraction is taken to be a constant (and so does not depend on covariates) the
mixture cure survival model is not identifiable. The dependence of our result on
covariates is analogous to identifiability results in the competing risks literature. A
number of authors have put forward identifiable competing risks models, and all of
the results depend on the presence of covariates in the models (Heckman and Honore
1989; Abbring and van den Berg 2003; Lee 2006).
Theorem 2. Under regularity conditions (c.1)–(c.7), θ̂ is a consistent estimator for
θ0 .
Theorem 3. Under regularity conditions (c.1) – (c.7) and (b.1)–(b.5), n1/2 (θ̂ − θ 0 )
converges weakly to a zero-mean Gaussian process. Conditional on the observed data,
∗

n1/2 (θ̂ − θ̂) has the same limiting distribution as n1/2 (θ̂ − θ 0 ).

10
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5.
5.1.

Inference Procedures and Weighted Bootstrap Scheme
Algorithm

With the large sample theory established, we propose an iterative algorithm to solve
estimating equations (8)–(10). To start, let t0 < t1 < . . . < tk be the ordered observed
failure times such that tk ≤ ν and t0 = 0. In practice, ν can be set equal to the 90th
or 95th percentile of the observed failure times.
(0)

Step 1: Choose initial values for β, γ, and H, denoted β̂ , γ̂ (0) , Ĥ (0) , respectively.
In general, the initial values for β and γ can be obtained from estimates that
ignore dependent censoring or potential cure fractions and one can let Ĥ (0) be
the constant value 0.
Step 2: Compute estimates for K(·). For example, if the crude censoring distribution
follows a time-dependent proportional hazards model, the calculation can be
done following Robins (1993).
Suppose that we have estimates for β, γ, and H from the (m − 1)th iteration; denote
these estimates by β̂

(m−1)

, γ̂ (m−1) , and Ĥ (m−1) .

Step 3: Recall that Ĥ(·) is a step function with jumps at tj , j = 1, . . . , k. Denote
the jump size at tj as Ĥ{tj }. For j = 1, . . . , k obtain estimates Ĥ (m) {tj },
(m−1)

in order, as solutions to UnH (tj ) = 0 with β and γ set equal to β̂
and
(m−1)
Rt
′ ˆ
γ̂ (m−1) , respectively. As Ĥ (m) (t) is a step function, 0 j eZi (u) β
dĤ (m) (u) =
ˆ (m−1)
Pj
Zi (tl )′ β
e
Ĥ (m) {tl }. Hence Ĥ (m) {tj } can be obtained recursively given
l=1

the estimates of Ĥ (m) {tl }, l ≤ j − 1. A unique solution is guaranteed to exist
due to the monotonicity of g.

11
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Step 4: To estimate β̂

(m)

, solve for β such that Unβ = 0 with γ set equal to γ̂ (m−1) and

H set equal to Ĥ (m) . The proof of Theorem 2 establishes that the derivative of
Unβ is negative definite, therefore the Newton-Raphson solution will be unique.
Step 5: To find γ̂ (m) , solve for γ such that Unγ = 0, with β = β̂
with the solution β̂

(m)

(m)

and H = Ĥ (m) . As

, the derivative of Unγ is negative definite (see the proof

of Theorem 2), so the Newton-Raphson method can be used to find a unique
solution.
Step 6: Repeat Steps 3 - 5 until predetermined convergence criteria are met.
5.2.

Weighted Bootstrap

To conduct inference on the parameter estimates we use a weighted bootstrap (Wellner and Zhan 1996), which is applicable even in this case with an infinite dimensional
P
nuisance parameter. Define µαi to be such that ni=1 µαi are the estimating equa-

tions for α. Recall that the estimates for θ = (α, β, γ, H) are approximate zeros of
P
Unj = ni=1 µji for j = α, β, γ, H. Choose a positive distribution B and generate

(bn1 , . . . , bnn ) such that B and (bn1 , . . . , bnn ) meet conditions (b.1)–(b.5) in the ApP
∗
∗
pendix. Denote the zeroes of ni=1 µjibni , j = α, β, γ, H as θ̂ = (α̂∗ , β̂ , γ̂ ∗ , Ĥ ∗ ).
∗

As stated in Theorem 3, the conditional distribution of n1/2 (θ̂ − θ̂ ) is asymptotically

equivalent to the unconditional distribution of n1/2 (θ̂ − θ 0 ). We can approximate the
∗

distribution of θ̂ by generating a large number of samples, (bn1 , . . . , bnn ), from B
∗

and for each sample calculating a realization of θ̂ . The empirical distribution can be
used to compute statistics for inference.

6.

Model Diagnostics

In practice, it is of substantial interest to verify whether the functional forms imposed on the regression models are plausible. To this end we propose a two-step
12
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model checking procedure. First, assumptions on the form of K need to be verified. If the assumed model for K is correct, the asymptotic distribution of Ξ(t) =
P
n−1/2 ni=1 q̃(Wi , t)′ µαi (α̂) will be a zero-mean Gaussian process, where q̃(·, ·) is a

weight function that is assumed to be known and bounded. Furthermore, if we let

(bn1 , . . . , bnn ) and α̂∗ be defined as in the previous section, we can approximate the
P
distribution of Ξ(t) with Ξ̃(t) = n−1/2 ni=1 q̃(Wi , t)′ (µαi (α̂)(1 − bni ) − µαi (α̂) +
µαi (α̂∗ )). That the distribution Ξ̃(t) approximates Ξ(t) follows from the argument
in Appendix C of Peng and Huang (2008).
A formal lack-of-fit test can be based upon the statistic TK = ||Ξ(t)||∞ , where
|| · ||∞ denotes the supremum norm on [0, ν]. We can generate a large number of
sample paths from Ξ̃(·) by repeatedly sampling new (bn1 , . . . , bnn ). A p-value for TK
can be estimated by the empirical proportion of Tk ≤ ||Ξ̃(t)||∞ . Similar arguments as
in Lin, Wei, and Ying (1993) show that this test is consistent against the alternative
that the model specification of K is false. A corresponding visual diagnostic method
is found by plotting a number of realizations of Ξ̃(·) and observing how extreme the
pattern of Ξ(·) looks in comparison to the simulated paths.
Once we are satisfied with the fit of K we can check the form of (3). Define
Mi (t, θ) = Yi(t)/Ki (t−)−G(γ ′ Xi)Sg (t, Z̄(t))− Ḡ(γ ′ Xi ). Consider the function Γ(t) =
P
n−1/2 ni=1 w(Zi , Xi, t)Mi (t, θ̂), where the weight function w(·, ·, ·) is assumed to be
known and bounded. If (3) is correctly specified and K(·) is consistently estimated,

Γ(t) converges to a zero-mean Gaussian process. We can approximate the distribution
of Γ(t) with the distribution of
−1/2

Γ̃(t) = n

n
X
i=1

∗

w(Zi , Xi, t)(Mi (t, θ̂)(1 − bni ) − Mi (t, θ̂) + Mi (t, θ̂ )),

(11)

∗

where bni and θ̂ are defined as in the previous section. If M(·, θ 0 ) is specified
13
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correctly, Γ(t) should have mean zero for any t. Following the arguments for Ξ we
can establish that the distribution of Γ̃ is asymptotically the same as the distribution
of Γ.
As in the model-checking procedure for K(·), a formal test for lack-of-fit can be
made based upon TS = kΓ(t)k∞ . As with the diagnostic method for K(·), we can calculate a p-value for TS (the corresponding test can be shown to be consistent against
the general alternative that (3) is not correctly specified) and develop a goodness-of-fit
plot.

Numerical Studies

7.
7.1.

Simulations

We evaluated the finite sample performance of the proposed methods with simulations. Two such studies are summarized in Table 1. We considered proportional odds
and proportional hazards models. Dependent censoring can occur when a covariate
that affects both the survival and censoring times is not included in the model. To
mimic this situation we generated two covariates for each subject: a Bernoulli(0.5)
random variable and a Uniform(0,1) random variable. The censoring times followed
a proportional hazards model with both the Bernoulli and Uniform random variables
as covariates. The latency survival times followed either the proportional hazards
or proportional odds models with both the Bernoulli and Uniform random variables
as covariates. The cure functions only depended on the Bernoulli random variable.
For the proportional hazards model we took H(t) = t and for the proportional odds
model we took H(t) = 2t.
In all of the analyses we only included one covariate in the cure function and
in the latency survival function, the Bernoulli random variable. To model the crude
hazard for censoring we used a proportional hazards model with the Bernoulli random
14
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variable as the only covariate. Bias, monte carlo standard error estimates, bootstrap
based standard error estimates, and estimates of the root mean squared error (RMSE)
for several different parameter configurations are presented in Table 1. We found the
“true” values of the misspecified latency survival parameters by generating a very
large dataset (sample size = 1,000,000) with the two covariates, but fitting the model
on the dataset with just one covariate.
To investigate the biases that occur when dependent censoring is ignored we compared our method to the method of Lu and Ying (2004) (we will refer to this method
as LY hereafter), which does not compensate for dependent censoring. Summaries for
bias, monte carlo standard errors, and estimates of RMSE can also be found in Table
1. The proposed method has the most significant gains over LY in estimating the
parameter associated with the cure proportion. The proposed method and LY have
comparable bias in estimating the latency survival parameter. In practice, if correct
estimates of the cure proportion are of primary interest, the proposed method can
reduce bias even when accounting for only some of the dependent censoring.
7.2.

SEER Prostate Cancer Data

We applied the proposed method to prostate cancer data from the SEER database,
using data released in 2004. Specifically, we looked at males diagnosed with prostate
cancer from the Detroit, Michigan area whose cancer stage was classified as local or
regional. The Detroit registry was one of the original nine SEER registries and so
has longer follow-up than the more recent registries. To avoid potential confounding related to prior cancer diagnoses, we restricted our sample to those men whose
prostate cancer was their first cancer diagnosis. The Federal Drug Administration
(FDA) approved the prostate-specific antigen (PSA) test for use in monitoring patients diagnosed with prostate cancer in 1986. The use of the PSA test for screening
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of prostate cancer increased dramatically starting in 1990, and so to avoid potential
biases associated with the new screening method we only considered cases diagnosed
up to 1989. Our random variable of interest was time from diagnosis of prostate
cancer to death from prostate cancer.
One question of interest was whether survival or cure fractions differed in this
dataset by race. Due to the small number of subjects in some racial categories in
this dataset we restricted our attention to the two largest racial groups, black and
white. There were 15,524 cases in the SEER database that met the criteria; 3,837
were classified as black and 11,687 were classified as white.
In this cohort, 3,717 people died of prostate cancer while 4,349 people died of
heart disease. These numbers are summarized in Table 2. Heart disease and prostate
cancer share the common risk factor of high fat diet (Wilson et al. 1998; Strom
et al. 2008). High fat diets have been shown to increase androgen levels in the body,
increase cholesterol levels, and are associated with increased consumption of Omega6 fatty acids. Increased levels of androgens have been shown to be associated with
prostate cancer cell proliferation (Fleshner et al. 2004; Pandini et al. 2005; Xu et al.
2006; Asirvatham et al. 2006). High cholesterol and Omega-6 fatty acids have been
shown to be associated with prostate carcinogenesis (Homma et al. 2004; HughesFulford et al. 2005; Zhuang et al. 2005; Bravi et al. 2006; Ritch et al. 2007). Further
complicating the relationship between heart disease and prostate cancer is the fact
that many men diagnosed with prostate cancer are treated with androgen therapy
to reduce hormone levels. This treatment has been shown to be associated with
an increased risk of death from heart disease (Keating et al. 2006). Given these
connections and the high rate of death from heart disease in this population, there is
some evidence that there may exist dependent censoring in this dataset.
Figure 1 shows the naı̈ve (assuming independent censoring) Kaplan-Meier survival
16
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plots for the two subgroups. We can observe that both curves plateau above 0.5,
indicating that a large proportion of the population may not die of prostate cancer.
While for the first several years the survival curves are indistinguishable, the white
subgroup’s survival tail is noticeably higher than the tail of the black group.
There are several situations when physicians consider patients to be cured of
prostate cancer. First, surgery (radical prostatectomy) and radiotherapy (externalbeam radiotherapy, brachytherapy, or both) in early stage prostate cancer patients
can entirely eradicate the disease, inducing a cure among a significant proportion
of patients (Hanlon and Hanks 2000; Jani and Hellman 2003). Also, improvements
in prostate cancer treatment have made it so that many prostate cancer patients
who are not cured are treated for chronic disease rather than acute disease, and
their probability of dying of prostate cancer is not elevated above that of the general
population (American Cancer Society 2007). Given these considerations, a model
that explicitly accounts for a cure proportion and allows for inference on the cure
proportion can be of use for this prostate cancer application.
We considered both proportional hazards and proportional odds models. Race
was a covariate for the survival and cure functions, denoted RS and RC , respectively.
The models also contain a time-dependent covariate written PSAS , which takes the
value one after the year 1985 and the value zero otherwise. This covariate can help
to account for changes in survival induced by the policy change in 1986 when the
FDA approved the PSA test to help monitor progress of prostate cancer. We modeled the crude hazard for censoring with a proportional hazards model containing
PSAS , RS , and covariates for grade, year of diagnosis, and age at diagnosis. We
took B ∼Exponential(1) and standard error estimates are based on 1000 bootstrap
replicates.
Figure 2 provides examples of model-checking plots for the time-dependent pro17
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portional hazards and proportional odds cure models. The plot of Equation (11)
against time for the proportional odds cure model does not appear to have mean zero
and the p-value from 1000 bootstrap replicates with B ∼ Exponential(1) is 0.008,
which indicates that the proportional odds cure model may not be appropriate. The
corresponding plot for the proportional hazards cure model shows an approximately
mean zero trend and the p-value from 1000 bootstrap replicates with B ∼ Exponential(1) is 0.416. These data suggest the proportional hazards cure model fits the data
better than the proportional odds cure model, so we will present results for the proportional hazards cure model. Results for the time-dependent model and a univariate
model containing only RS and RC can be found in Table 3.
The race covariate is significant in the univariate model for both the survival and
cure functions. The signs of the estimates indicate that black race is associated with
worse survival and a smaller probability of being cured. These covariates remain significant in the time-dependent model, though the time-dependent covariate indicating
PSA approval is not significant.
We contrast our univariate results with alternative methods in Tables 4 and 5.
All models contain one covariate denoting race. The standard proportional hazards
model (ignoring possible cure fractions and dependent censoring) estimate is almost
identical to the competing risks proportional hazards model estimate with deaths from
other causes treated as censored events (Fine and Gray 1999). The three parameter
values presented in Table 4 have different interpretations. The parameter estimate
from our model has the interpretation of the log-hazard ratio for subjects who are not
cured. The standard proportional hazards model parameter has the interpretation
of the log-hazard ratio assuming the population is composed entirely of persons who
are not cured. The log-hazard ratio for the subdistribution for death from prostate
cancer are not easily interpretable, as noted in Fine and Gray (1999).
18

Hosted by The Berkeley Electronic Press

Under the assumption of independent censoring, the tail end of the Kaplan-Meier
curve can estimate the proportion of cured subjects in a sample (Maller and Zhou
1992). Table 5 compares estimates of the tail of the Kaplan-Meier survival function
stratified by race to estimates of the cure proportion found from transforming the
regression results from the our proportional hazards cure model. The proportional
hazards cure model has a smaller cure fraction than the tail end of the Kaplan-Meier
plot indicates, and the confidence intervals for the estimates do not overlap.
As a referee noted, competing risks models (Prentice et al. 1978; Fine and Gray
1999) are a useful way to model survival data with the potential for dependent censoring. However, this type of analysis may not be ideal for this specific application.
First, competing risks models can characterize the crude risk of failure for a specific
failure type, but do so without removing dependent risks (Pepe and Mori 1993). We
wish to evaluate the effect of race on prostate cancer survival, but these competing
risks models will not allow for the direct covariate interpretation we are interested
in. Second, a subject who is cured of prostate cancer could die of heart disease (a
competing risk). Therefore the probability of being cured is not readily modeled using
the existing competing risk framework, in contrast to the model we proposed.

8.

Discussion

This paper provides a unified framework for a class of transformation cure models that
allow for dependent censoring. We utilize an inverse censoring probability formula
to develop unbiased estimating equations. Our method allows one to estimate cure
fractions more accurately in cases where there is dependence between censoring and
survival times. We also develop a weighted bootstrap for inference procedures and
supply a method to check whether the model specification is adequate.
Extending our estimation procedure to be able to incorporate internal time19
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dependent covariates is a subject of future research. This extension would allow
for a greater range of application in dependent censoring situations. A common
cause of dependent censoring is excluding covariates related to both the survival and
censoring times. This is an issue in any model, including models with only timeindependent covariates. As shown in our simulation study, our method can decrease
bias in situations with only time-independent covariates.
Rigorous testing for whether there is sufficient follow-up to identify cure proportions is difficult even without dependent censoring. A test for sufficient follow-up
in the presence of dependent censoring may deserve a separate paper. A number of
tests for sufficient follow-up in cure survival situations have been put forward (Maller
and Zhou 1994, 1995; Klebanov and Yakovlev 2007). These tests, combined with
subject matter specific knowledge on whether a mixture cure formulation is suitable,
can provide information to allow an investigator to decide whether it is appropriate
to use this model.

Appendix: Technical Details
Before we present the asymptotic results we will review and define some notation.
All expectations are with respect to the true distributions of all random variables
involved. Denote the Euclidean norm as || · ||, the supremum norm on [0, ν] as || · ||∞,
and the norm corresponding to the parameters of α as || · ||α . For example, if we
assumed the crude hazard for censoring followed a proportional hazards form, our
model would have two parameters: αE , a Euclidean parameter associated with W(·),
and αΛ , associated with the cumulative baseline hazard. In this case a sensible
choice for ||α − α0 ||α would be ||αE − α0E || + ||αΛ − α0Λ ||∞ . Define ||θ − θ 0 || =
||α − α0 ||α + ||β − β 0 || + ||γ − γ 0 || + ||H − H0 ||∞ . Let a single superscript dot denote
derivatives and a double superscript dot denote second derivatives.
20
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Consider the following regularity conditions:
(c.1) the covariates Xi and the covariate processes Zi (·) and Wi (·) are uniformly
bounded, have nondegenerate variance-covariance matrices, and are cadlag for
i = 1, . . . , n;
(c.2) φ0 = (β 0 , γ 0 ) is a point in a bounded, open, convex subset of Rξ+κ ;
(c.3) the transformation function g is twice differentiable. The function g, its derivative ġ, and its second derivative g̈ are all Lipschitz;
(c.4) H0 (t) is differentiable and is of bounded variation over [0, ν];
(c.5) E(n−1 U̇nφ (θ)|φ=φ ) is nondegenerate with probability 1;
0

(c.6) max Ni (ν) > 0, i = 1, . . . , n;
(c.7) K(·) is uniformly bounded away from 0 on [0, ν]. The estimating equation Unα
meets conditions 1, 3, and 4 of Theorem 2. Unα is Fréchet differentiable at α0
and the derivative is continuously invertible;
(b.1) the vectors (bn1 , . . . , bnn )′ are exchangeable for all n = 1, 2, . . .;
(b.2) bni ≥ 0 for all n and all i and

Pn

i=1 bni

(b.3) the L2,1 norm of bn1 is bounded, i.e.
(b.4) limψ→∞ lim supn→∞
(b.5) n−1

Pn

i=1 (bni

P

t≥ψ

= n for all n;

R∞p
0

PB (bn1 ≥ u) du ≤ M ∗ < ∞;

t2 P (bn1 ≥ t) = 0;

− 1)2 → c2 > 0 in PB -probability.

Conditions (c.1)-(c.5) are standard assumptions in survival analysis literature.
(c.6) is used in the proofs of Theorems 1 and 2. (c.7) requires that the estimates
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for the weight function, K, meet the same regularity conditions that we impose on
β, γ, and H. These conditions have been previously shown for a variety of survival
functions (e.g. van der Vaart 1998, Section 25.12 for the proportional hazards model).
Conditions (b.1) - (b.5) are met by most positive distributions by defining bni =
b′i /b̄′n , where b′i is an observed realization from the bootstrap distribution, B, and b̄′
denotes the average of n observed realizations. If B ∼ Exponential(1), B meets all
the regularity conditions.
The following are sketches of the proofs. More complete details can be found in a
technical report available from the first author.
Proof of Theorem 1
We want to show that
nZ

t

o
exp(β ′ Z(u)) dH(u)
0
nZ t
o
′
′
′
= Ḡ(γ̃ X) + G(γ̃ X)g
exp(β̃ Z(u)) dH̃(u)
′

′

Ḡ(γ X) + G(γ X)g

(12)

0

for all t ∈ [0, ν] with probability 1 implies that γ = γ̃, β = β̃, H = H̃. Equation (12)
implies that there exists a time-independent constant v ∗ (possibly random) such that
o
′
exp(β̃ Z(u)) dH̃(u) − 1
nR
o
= v∗
t
′
g 0 exp(β Z(u)) dH(u) − 1
g

nR

t
0

for all t ∈ [0, ν]. Rewrite β̃ = β + ̟ and H̃(t) = H(t) + a
nonrandom function ω(u) and a ∈ R. Express v ∗ as
g{

Rt

R0t
g{ 0

Rt
0

ω(u) dH(u) for some

′

exp(β̃ Z(u)) dH̃(u)} − 1

exp(β ′ Z(u)) dH(u)} − 1
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Rt
g{ 0 (1 + aω(u)) exp(Z(u)′ (β + ̟)) dH(u)} − 1
=
Rt
g{ 0 exp(β ′ Z(u)) dH(u)} − 1

(13)

for all t ∈ [0, ν]. It follows that (13) is constant with respect to t if and only if ̟ = 0
and a = 0. To see that this is the case, use the mean value theorem and write the
right hand side of (13) as

1 + ḡ(t)

Z

t

exp(β ′ Z(u))[Z(u)′ ̟ + a] dH(u),

(14)

0

where

Rt
′
ġ{ 0 {1 + āω(u)} exp(β̄ Z(u)) dH(u)}
,
ḡ(t) =
Rt
g{ 0 exp(β ′ Z(u)) dH(u)} − 1

β̄ = β + s̄β̃ and ā = s̄a for some constant s̄ ∈ [0, 1]. Equation (14) is independent
of t if and only if ̟ = 0 and a = 0. Hence β̃ = β and H̃ = H. Therefore, a
reëxamination of (12) yields that G(γ ′ X) = G(γ̃ ′ X) with probability 1. Since the
logistic function G(·) is invertible, it follows that γ ′ X = γ̃ ′ X or (γ − γ̃)′ X = 0 with
probability 1. As X has a nondegenerate variance-covariance matrix, γ = γ̃.
Proof of Theorem 2
First consider the convergence of Ĥ(t, φ0 , α0 ), which is solved recursively from
(10) with φ and K(·) fixed at the true values, φ0 and K0 (·). Let H be the set of all
nondecreasing, nonnegative, finite step functions with H(·) ∈ H such that H(0) = 0
and H(·) jumps only at the observed failure times from the data, t1 < . . . < tk ≤ ν.
We want to show that ||Ĥ(t, φ0 , α0 ) − H0 (t)||∞ → 0 almost surely as n → ∞. Define
the mapping Q on H as

Q(H)(t) =

n Z
X
i=1

0

t

dNi (u)/Ki(u−) + G(γ ′0 Xi) dSg (Z̄i (t), t, β 0 ).
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For an arbitrary but fixed ε′ > 0 consider H1 ∈ H and H2 ∈ H such that ||H1 −
H2 ||∞ ≥ ε′ . Denote the jump size of Hl at tj as Hl {tj }, l = 1, 2. Write Q(H1 )(t) −
P
Pn
′
′
Q(H2 )(t) =
w
a
where
w
=
j
j
j
tj ≤t
i=1 G(γ 0 Xi )ġ(si ) exp(β 0 Zi (tj )), 0 ≤ si ≤
Rt
Rt
| 0 exp(β ′0 Zi (u))d H1(u) − 0 exp(β ′0 Zi (u))d H2(u)|, and aj = H1 {tj } − H2 {tj }. Since

kH1 (t) − H2 (t)k∞ ≥ ε′ /2, there must exist tj0 such that aj0 = |H1 {tj0 } − H2 {tj0 }| ≥
ε′ /2k. Note that since Z(·) and X are uniformly bounded there must exist some finite

c̄ such that n/c̄ ≤ wj ≤ nc̄ for j = 1, . . . , k.
P
P
Suppose that | tj ≤tj wj aj | ≤ ε′ n/4kc̄. It follows that | tj ≤tj −1 wj aj | ≥ |wj0 aj0 |−
0
0
P
′
′
′
′
ε n/4kc̄ ≥ ε n/2kc̄ − ε n/4kc̄ = ε n/4kc̄. Therefore, either | tj ≤tj wj aj | ≥ ε′ n/4kc̄
0
P
′
or | tj ≤tj −1 wj aj | ≥ ε n/4kc̄. Hence
0

k

n
X
i=1

G(γ ′0 Xi)[Sg (t, Z̄i (t), β 0 , H1) − Sg (t, Z̄i (t), β 0 , H2 )]k∞ ≥ ε′n/4kc̄ ≥ ε′ /4c̄.

Select H ′ ∈ H such that H ′(tj ) = H0 (tj ) for i = 1, . . . , k. The law of large numbers
and the continuity of H0 imply that kQ(H ′ )(t)k∞ → 0 almost surely as n → ∞. We
defined Ĥ(t, φ0 , α0 ) such that Q(Ĥ(t, φ0 , α0 )) = op (1) for all t ∈ [0, ν], which implies
that kQ(H ′)(t) − Q{Ĥ(φ0 , α0 )}(t)k∞ → 0 almost surely as n → ∞. Therefore
Ĥ(·, φ0 , α0 ) is in an ε′ neighborhood of H ′ in [0, ν] under || · ||∞ with probability
1. Using the facts that Ĥ(·, φ0 , α0 ) and H0 are monotone, and that ε′ > 0 can be
made arbitrarily small, we conclude that ||Ĥ(·, φ0 , α0 ) − H0 (·)||∞ → 0 in [0, ν] almost
surely.
We apply the inverse function theorem to prove consistency for φ (Foutz 1977).
That the estimating equations for β and γ are asymptotically unbiased follows from
the consistency of K̂(·) and the convergence of Ĥ(·, φ0 , α0 ). Tedious but straightforward calculations can show that En−1 U̇nφ (θ)|φ=φ converges uniformly in a
0

neighborhood of the true parameters and is negative definite. Hence φ is consis24
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tent. Finally, the consistency of Ĥ(·, θ) follows immediately from the convergence of
H(·, φ0 , α0 ) , the consistency of φ and K (consistency of K is assumed in (c.7)), and
the continuity of Ĥ(·, φ) with respect to φ and K(·).
Proof of Theorem 3
We use Theorem 3.3.5 of van der Vaart and Wellner (1996) and Theorem 3.1 from
Wellner and Zhan (1996). In the following, define Uj = Eµj for j = α, β, γ, H and
U = (Uα , . . . , UH ), where the µj are defined as in Section 4. Let Hβ and Hγ to
be finite sets with same cardinality as the parameters and let HH = {ht = 1[0,t] : t ∈
[0, ν]}. The following four conditions need to be verified:
√
√
1. For j = α, β, γ, H and for any δn → 0: sup{|| n(Unj − Uj )(θ) − n(Unj −
√
Uj )(θ 0 )||j /1 + n||θ − θ 0 || : ||θ − θ 0 || ≤ δn } = op (1), where || · ||j denotes the
norm associated with parameter j.
2. U is Fréchet differentiable at θ 0 with derivative denoted U̇0 , and U̇0 has a
continuous inverse.
3. θ̂ is consistent for θ 0 and Un (θ̂) = op (n−1/2 ).
4. If D̃nj is the envelope function of the class Dnj ≡ {

µj (θ )(h)−µj (θ 0 )(h)
√
1+ n||θ −θ 0 ||

: h ∈

Hj , ||θ − θ 0 || < δn }, for every δn → 0 and j = α, β, γ, H,
lim lim sup sup t2 P (D̃nj (X, W, Z, ∆) > t) = 0.

ψ→∞

n→∞

t≥ψ

Conditions 3 and 4 clearly hold in this situation. Theorem 2 and (c.5) establish
the consistency of θ̂, and the second requirement of Condition 3 holds by definition
of θ̂. Let M̃ = max(||Z(t)||∞ , ||X||, 2) and let D̃nβ = D̃nγ = D̃nH = 2M̃ . It follows
that Condition 4 is met for j = β, γ, H. Condition 4 is met for j = α by (c.7).
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For j = β, γ, H, Condition 1 can be shown using standard arguments by building
up Donsker classes of terms (Parner 1998; van der Vaart and Wellner 1996) and
by using the continuity of K, G, and g and the pointwise convergence of θ to θ 0 .
Condition 1 holds for j = α by (c.7).
The last step is to verify Condition 2. Write the Fréchet derivative, U̇0 , of U at θ 0


B C
as a partitioned matrix:
, where B corresponds to the the Fréchet derivative
D E
of Uα with respect to α evaluated at θ 0 ; C to the Fréchet derivative of Uα with
respect to β, γ, and H evaluated at θ 0 ; D to the Fréchet derivative of Uβ , Uγ , UH
with respect to α evaluated at θ 0 ; and E to the Fréchet derivative of Uβ , Uγ , UH with
respect to β, γ, and H evaluated at θ 0 . The inverse of this partitioned matrix can

 −1
B + B−1 CF−1 DB−1 −B−1 CF−1
, where F = E − DB−1 C (Stapleton
be written as
−F−1 DB−1
F−1
1995). Therefore, to prove that the partitioned matrix is continuously invertible,
one only needs to show that B and F are continuously invertible. Since Uα is not a
function of β, γ, or H, C is the zero matrix and we only need to show that B and E
are continuously invertible. B is continuously invertible by (c.5).
To verify that E is continuously invertible, write E as a partitioned matrix and


U̇p U̇q
use the same argument as above. Specifically, write: E =
, where U̇p
U̇r U̇s
is the derivative of (Uβ , Uγ ) with respect to β and γ evaluated at θ 0 ; U̇q is the
derivative of (Uβ , Uγ ) with respect to H evaluated at θ 0 ; U̇r is the derivative of
UH with respect to β and γ evaluated at θ 0 ; and U̇s is the derivative of UH with
respect to H evaluated at θ 0 . We need to show that U̇p and U̇s − U̇r U̇−1
p U̇q are
continuously invertible. U̇p is finite dimensional and so continuous invertibility is a
consequence of it being one-to-one. U̇s can be shown to be continuously invertible by
direct computation, and U̇r U̇−1
p U̇q can be shown to be compact by invoking Helly’s
26
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selection theorem and the dominated convergence theorem. Direct calculation can
show that (U̇s − U̇r U̇−1
p U̇q )[A] = 0 if and only if ||A||∞ = 0. We can therefore
conclude that U̇s − U̇r U̇−1
p U̇q is one-to-one. The sum of a continuously invertible
operator and a compact operator is continuously invertible if the sum is one-to-one
(Rudin 1987). Therefore U̇s − U̇r U̇−1
p U̇q is continuously invertible and the result
follows.
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Table 1: Simulation results
Proportional Hazards Model

Parameter
β
γ0
γ1

True Values
-0.507
1
-1

Bias
0.136
0.133
0.038

Our Method
SEM C SEB
0.162 0.175
0.147 0.151
0.164 0.209

β
γ0
γ1

-0.507
0.8
-0.75

-0.014
-0.074
-0.017

0.164
0.147
0.191

0.236
0.160
0.212

RMSE
0.212
0.198
0.168
0.165
0.165
0.192

Lu and Ying (2004)
Bias SEM C RMSE
0.040 0.126
0.132
-0.136 0.148
0.201
0.078 0.203
0.217
0.017
-0.103
0.054

0.117
0.145
0.199

0.118
0.179
0.206

Proportional Odds Model

Parameter
β
γ0
γ1

True Values
-0.608
1
-1

Bias
0.017
-0.133
0.101

Our Method
SEM C SEB
0.173 0.232
0.219 0.209
0.299 0.274

β
γ0
γ1

-0.608
0.8
-0.75

-0.241
-0.137
0.171

0.317
0.214
0.295

0.370
0.223
0.300

RMSE
0.174
0.256
0.316
0.398
0.254
0.341

Lu and Ying (2004)
Bias SEM C RMSE
0.243 0.133
0.277
0.455 0.255
0.525
-0.353 0.303
0.465
0.197
0.389
-0.213

0.130
0.234
0.278

0.236
0.454
0.350

Bias = average of estimate - true value
SEM C = standard deviation of estimates
SEB = mean of bootstrap standard errors
RMSE = (Bias2 + SE2M C )0.5

Table 2: Summary of causes of death among SEER data
Cause of Death
N (total=15,524) %
SEER Code*
Prostate Cancer
3,717
23.9
28010
Diseases of the Heart
4,349
28.0
50060
Alive
2,208
14.2
00000
Other
5,250
33.8
all others
*Based on ICD-10 codes, using SEER COD Recode 9/17/2004
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Table 3: SEER data results for a proportional hazards cure model. Parameter estimates and associated standard errors from the regression models are provided. Estimates with the subscript S can be interpreted as the log-hazard ratio for non-cured
subjects. Estimates with the subscript C can be interpreted as the log-odds for being
not cured. Black race is the reference category for the race parameters.

Parameter
RaceS
InterceptC
RaceC

Univariate
Estimate
Standard error*
-0.129
0.033
0.245
0.008
-0.169
0.011

Parameter
RaceS
PSAS
InterceptC
RaceC

Time-Dependent
Estimate
Standard error*
-0.123
0.031
-0.083
0.042
0.245
0.008
-0.170
0.011

*All standard error estimates are based on 1000
bootstrap replications with B ∼Exponential(1).

Table 4: Parameter estimates for proportional hazards functions for three different
models. Black race is the reference category for each of the models.
Model
Parameter estimate Standard Error
Our proportional hazards cure model
-0.129
0.033
Standard proportional hazards model
-0.139
0.037
Competing risks proportional hazards model
-0.138
0.037
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Table 5: Estimates of the proportion of men cured of prostate cancer: (1) from the
tail of the Kaplan-Meier survival curve stratified by race and (2) from transforming
the regression results from our proportional hazards cure model.
Cure estimate Confidence Interval
Our proportional hazards cure model
CureB
0.439
(0.435, 0.443)
CureW
0.481
(0.474, 0.481)

0.6
0.4
0.0

0.2

Survival Probability

0.8

1.0

Naı̈ve Kaplan-Meier tail estimates
CureB
0.566
(0.540, 0.593)
CureW
0.594
(0.578, 0.610)

0

50

100

150

200

250

300

350

Time (Months)

Figure 1: Naı̈ve Kaplan-Meier curves (ignoring potential dependent censoring) for
survival comparing white subgroup (dashed line) to the black subgroup (solid line).
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Figure 2: Model checking plots. Twenty-five random sample paths are plotted in grey
with the observed paths marked in black.
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